What's your experience with side effects?

Are you or someone you know currently taking a TKI or targeted treatment for EGFR+ lung cancer?

We’ve been invited to present the patient perspective at the upcoming European Society for Medical Oncology (ESMO) conference next month. Our goal is to highlight the real-world experiences of those dealing with the side effects of TKIs and targeted therapies.

To ensure we represent as many voices as possible, we’ve created a brief survey designed to gather a wide range of patient experiences.

Please take a few minutes to complete our survey and help us bring the patient voice to the forefront at ESMO. Your contributions will inform our talk and help shape the conversation about patient experiences with these treatments.

Thank you for your support!

UPDATE : The survey deadline has been extended to 31st August.

Professor Gini Harrison, EGFR+ UK Research Trustee